LoopLab’s vision is to revolutionize the medical treatment of immunological diseases by combining our extensive expertise in immunology, molecular biology, and virology to create a groundbreaking new drug modality. With this approach, we are equipping disease-relevant cells to become powerful drug nanofactories capable of targeting multiple disease hallmarks simultaneously. This innovative therapeutic strategy has the potential to create a new era of advanced and comprehensive treatments.
Company Details
- Employees
- 19
- Founded
- -
- Address
- Muthgasse, Vienna,1190,austria
- Industry
- Biotechnology Research
- NAICS
-
Research and Development in Biotechnology (except Nanobiotechnology)
- Website
- http://www.looplabbio.com
- Keywords
- drug development, drug discovery, biotech, autoimmune disease, immunological disease, inflammation, atherosclerosis.
- HQ
- Vienna
Looplab Bio Questions
Looplab Bio's website is http://www.looplabbio.com
Looplab Bio's LinkedIn profile is https://at.linkedin.com/company/looplabbio
Looplab Bio has
19 employees.
View email and phone details for 19
employees at Looplab Bio.
Looplab Bio's industry is
Biotechnology Research
Looplab Bio's top competitors are
Oncoone,
Affiris Ag,
Solgate,
Lisavienna,
Bespark*bio,
Valneva,
Proxygen,
Ribbon Bio,
Biotech Austria,
Valanx Biotech.
Looplab Bio's categories are Biotechnology Research
Looplab Bio's founding year is 2023
